Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, Ivory J, Strifler L, Ashoor H, MacDonald H, Reynen E, Robson R, Ho J, Ng C, Antony J, Mrklas K, Hutton B, Hemmelgarn BR, Moher D, Straus SE.

BMC Med. 2015 Jun 18;13:142. doi: 10.1186/s12916-015-0379-3.

2.

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

Tricco AC, Soobiah C, Hui W, Antony J, Struchkov V, Hutton B, Hemmelgarn B, Moher D, Straus SE.

BMC Pharmacol Toxicol. 2015 Jan 26;16:1. doi: 10.1186/2050-6511-16-1.

3.

The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy-Induced Nausea and Vomiting: Systematic Review of the Literature.

Broder MS, Faria C, Powers A, Sunderji J, Cherepanov D.

Am Health Drug Benefits. 2014 May;7(3):171-82. Review.

4.

Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.

Gandhi SV, Rodriguez W, Khan M, Polli JE.

AAPS PharmSciTech. 2014 Jun;15(3):601-11. doi: 10.1208/s12249-014-0084-0. Epub 2014 Feb 21.

5.
6.

Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.

Botrel TE, Clark OA, Clark L, Paladini L, Faleiros E, Pegoretti B.

Support Care Cancer. 2011 Jun;19(6):823-32. doi: 10.1007/s00520-010-0908-8. Epub 2010 May 22. Review.

PMID:
20495832
7.

[Meta-analysis of phase III studies with palonosetron in the prevention of vomiting induced by moderately emetogenic chemotherapy].

Di Maio M, Gallo C, Perrone F.

Tumori. 2008 Mar-Apr;94(2):suppl 14-22. Italian. No abstract available.

PMID:
18564621
8.

[Prevention of postoperative nausea and vomiting].

Ahlburg P, Nielsen JO.

Ugeskr Laeger. 2007 Aug 13;169(33):2622-4. Review. Danish. No abstract available.

PMID:
17725908
9.

[Prevention and treatment of postoperative nausea and vomiting in children. An evidence-based approach].

Tramèr MR.

Ann Fr Anesth Reanim. 2007 Jun;26(6):529-34. Epub 2007 May 22. Review. French.

PMID:
17521856
10.

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.

Jordan K, Hinke A, Grothey A, Voigt W, Arnold D, Wolf HH, Schmoll HJ.

Support Care Cancer. 2007 Sep;15(9):1023-33. Epub 2007 Jan 5.

PMID:
17205281
11.

Prophylaxis of postoperative vomiting in children undergoing tonsillectomy: a systematic review and meta-analysis.

Bolton CM, Myles PS, Nolan T, Sterne JA.

Br J Anaesth. 2006 Nov;97(5):593-604. Epub 2006 Sep 26. Review.

12.

Drugs for preventing postoperative nausea and vomiting.

Carlisle JB, Stevenson CA.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004125. Review.

PMID:
16856030
14.

Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV.

Leslie JB, Gan TJ.

Ann Pharmacother. 2006 May;40(5):856-72. Epub 2006 May 2.

PMID:
16670360
15.

New antiemetic drugs.

Roila F, Fatigoni S.

Ann Oncol. 2006 Mar;17 Suppl 2:ii96-100. Review.

16.

The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.

Board T, Board R.

AORN J. 2006 Jan;83(1):209-16, 219-20. Review.

PMID:
16528908
17.

Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting.

Holdsworth MT, Vo-Nguyen T.

Ann Pharmacother. 2005 Nov;39(11):1903-10. Epub 2005 Oct 4. Review.

PMID:
16204394
19.

Single-dose parenteral pharmacological interventions for the prevention of postoperative shivering: a quantitative systematic review of randomized controlled trials.

Kranke P, Eberhart LH, Roewer N, Tramèr MR.

Anesth Analg. 2004 Sep;99(3):718-27, table of contents. Review.

PMID:
15333401
20.

5-HT3 receptor antagonists for prevention of late acute-onset emesis.

Constenla M.

Ann Pharmacother. 2004 Oct;38(10):1683-91. Epub 2004 Aug 17. Review.

PMID:
15316106
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk